PRONAL C1/4 CAPSULES DIN 02229735
Health Canada record
| Active ingredient(s) | BUTALBITAL 50 MG; CAFFEINE 40 MG; ACETYLSALICYLIC ACID 330 MG; CODEINE PHOSPHATE 15 MG |
|---|---|
| Dosage form | Capsule |
| Route | Oral |
| Schedule | NARCOTICS (CDSA I) |
| Class | Human |
| ATC | N02AA79 CODEIN, COMBINATIONS WITH PSYCHOLEPTICS |
| Original market date | 25-Jun-2009 |
| Current status date | 18-Jan-2013 |
| Source | Health Canada DPD |
Establishment licence of the holder
Pro Doc Limitée — licence 100182, currently licensed, last inspection rating C (2025-08-11).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing BUTALBITAL
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02554690 | APO-BUTALBITAL-ACETYLSALICYLIC ACID-CAFFEINE | APOTEX INC | Capsule | BUTALBITAL 50 MG; CAFFEINE 40 MG; ACETYLSALICYLIC ACID 330 MG | Marketed |
| 00226327 | FIORINAL | ARALEZ PHARMACEUTICALS CANADA INC | Capsule | BUTALBITAL 50 MG; CAFFEINE 40 MG; ACETYLSALICYLIC ACID 330 MG | Marketed |
| 00608211 | TEVA-TECNAL | TEVA CANADA LIMITED | Tablet | BUTALBITAL 50 MG; CAFFEINE 40 MG; ACETYLSALICYLIC ACID 330 MG | Marketed |
| 00608181 | TEVA-TECNAL C 1/2 | TEVA CANADA LIMITED | Capsule | BUTALBITAL 50 MG; CAFFEINE 40 MG; ACETYLSALICYLIC ACID 330 MG; CODEINE PHOSPHATE 30 MG | Marketed |
| 00608203 | TEVA-TECNAL C 1/4 | TEVA CANADA LIMITED | Capsule | BUTALBITAL 50 MG; CAFFEINE 40 MG; ACETYLSALICYLIC ACID 330 MG; CODEINE PHOSPHATE 15 MG | Marketed |
| 01971409 | TRIANAL TABLET | LABORATOIRE RIVA INC. | Tablet | BUTALBITAL 50 MG; CAFFEINE 40 MG; ACETYLSALICYLIC ACID 330 MG | Marketed |
| 00275328 | FIORINAL TAB | NOVARTIS PHARMACEUTICALS CANADA INC | Tablet | BUTALBITAL 50 MG; CAFFEINE 40 MG; ACETYLSALICYLIC ACID 330 MG | Cancelled Post Market |
| 02229734 | PRONAL - C1/2 CAPSULES | PRO DOC LIMITEE | Capsule | BUTALBITAL 50 MG; CAFFEINE 40 MG; ACETYLSALICYLIC ACID 330 MG; CODEINE PHOSPHATE 30 MG | Cancelled Post Market |
| 02229733 | PRONAL CAPSULES | PRO DOC LIMITEE | Capsule | BUTALBITAL 50 MG; CAFFEINE 40 MG; ACETYLSALICYLIC ACID 330 MG | Cancelled Post Market |
| 02229736 | PRONAL TABLETS | PRO DOC LIMITEE | Tablet | BUTALBITAL 50 MG; CAFFEINE 40 MG; ACETYLSALICYLIC ACID 330 MG | Cancelled Post Market |
| 01971387 | TRIANAL C½ | LABORATOIRE RIVA INC. | Capsule | BUTALBITAL 50 MG; CAFFEINE 40 MG; ACETYLSALICYLIC ACID 330 MG; CODEINE PHOSPHATE 30 MG | Dormant |
| 02242406 | TRIANAL C¼ | LABORATOIRE RIVA INC. | Capsule | BUTALBITAL 50 MG; ACETYLSALICYLIC ACID 330 MG; CAFFEINE 40 MG; CODEINE PHOSPHATE 15 MG | Dormant |
| 01971417 | TRIANAL CAPSULES | LABORATOIRE RIVA INC. | Capsule | BUTALBITAL 50 MG; CAFFEINE 40 MG; ACETYLSALICYLIC ACID 330 MG | Dormant |
International API supply for BUTALBITAL
3 active FDA Drug Master Files.
Request a quote for PRONAL C1/4 CAPSULES